Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allison Martin

Showing results (71-80 of 113) with videos related to

Pageof 12
Sort By:
Translational Oncology|October 7, 2018
Targeting DDX3 in Medulloblastoma Using the Small Molecule Inhibitor RK-33Saritha Tantravedi, Farhad Vesuna, Paul T Winnard, et al.
Urologic Oncology|August 23, 2018
The association between facility case volume and overall survival in patients with metastatic renal cell carcinoma in the targeted therapy eraYu-Wei Chen, Moshe C Ornstein, Laura S Wood, et al.
The Lancet. Respiratory Medicine|September 2, 2024
Efficacy and safety of gefapixant in women with chronic cough and cough-induced stress urinary incontinence: a phase 3b, randomised, multicentre, double-blind, placebo-controlled trialSurinder S Birring, Linda Cardozo, Roger Dmochowski, et al.
AIDS (London, England)|April 21, 2004
Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension StudyAllison Martin, Don E Smith, Andrew Carr, et al.
Journal for Immunotherapy of Cancer|May 18, 2019
A phase II trial of intermittent nivolumab in patients with metastatic renal cell carcinoma (mRCC) who have received prior anti-angiogenic therapyMoshe C Ornstein, Laura S Wood, Brian P Hobbs, et al.
Clinical Genitourinary Cancer|January 20, 2024
Safety and Efficacy Outcomes in Immune Checkpoint Inhibitor-Treated Patients With Metastatic Urothelial Carcinoma Requiring Treatment Interruption or Discontinuation Due to Immune-Related Adverse EventsAmanda Nizam, Ryan K Rader, Alice Tzeng, et al.
Therapeutic Advances in Respiratory Disease|September 5, 2024
Content validity of the Leicester Cough Questionnaire in adults with refractory or unexplained chronic cough: a qualitative interview studyAllison Martin Nguyen, Carmen La Rosa, Alexandra G Cornell, et al.
Plos One|November 9, 2013
HIV lipodystrophy in participants randomised to lopinavir/ritonavir (LPV/r) +2-3 nucleoside/nucleotide reverse transcriptase inhibitors (N(t)RTI) or LPV/r + raltegravir as second-line antiretroviral therapyAllison Martin, Cecilia L Moore, Patrick W G Mallon, et al.
Targeted Oncology|July 15, 2020
Identifying Prostate Surface Antigen Patterns of Change in Patients with Metastatic Hormone Sensitive Prostate Cancer Treated with Abiraterone and PrednisoneIris Y Sheng, Jaleh Fallah, Ruby Gupta, et al.
Lung|March 6, 2023
The Efficacy and Safety of Gefapixant in a Phase 3b Trial of Patients with Recent-Onset Chronic CoughLorcan McGarvey, Mandel Sher, Yury Grigorievich Shvarts, et al.
Pageof 12

Showing results (71-80 of 113) with videos related to

Sort By:
Pageof 12
Translational Oncology|October 7, 2018
Targeting DDX3 in Medulloblastoma Using the Small Molecule Inhibitor RK-33Saritha Tantravedi, Farhad Vesuna, Paul T Winnard, et al.
Urologic Oncology|August 23, 2018
The association between facility case volume and overall survival in patients with metastatic renal cell carcinoma in the targeted therapy eraYu-Wei Chen, Moshe C Ornstein, Laura S Wood, et al.
The Lancet. Respiratory Medicine|September 2, 2024
Efficacy and safety of gefapixant in women with chronic cough and cough-induced stress urinary incontinence: a phase 3b, randomised, multicentre, double-blind, placebo-controlled trialSurinder S Birring, Linda Cardozo, Roger Dmochowski, et al.
AIDS (London, England)|April 21, 2004
Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension StudyAllison Martin, Don E Smith, Andrew Carr, et al.
Journal for Immunotherapy of Cancer|May 18, 2019
A phase II trial of intermittent nivolumab in patients with metastatic renal cell carcinoma (mRCC) who have received prior anti-angiogenic therapyMoshe C Ornstein, Laura S Wood, Brian P Hobbs, et al.
Clinical Genitourinary Cancer|January 20, 2024
Safety and Efficacy Outcomes in Immune Checkpoint Inhibitor-Treated Patients With Metastatic Urothelial Carcinoma Requiring Treatment Interruption or Discontinuation Due to Immune-Related Adverse EventsAmanda Nizam, Ryan K Rader, Alice Tzeng, et al.
Therapeutic Advances in Respiratory Disease|September 5, 2024
Content validity of the Leicester Cough Questionnaire in adults with refractory or unexplained chronic cough: a qualitative interview studyAllison Martin Nguyen, Carmen La Rosa, Alexandra G Cornell, et al.
Plos One|November 9, 2013
HIV lipodystrophy in participants randomised to lopinavir/ritonavir (LPV/r) +2-3 nucleoside/nucleotide reverse transcriptase inhibitors (N(t)RTI) or LPV/r + raltegravir as second-line antiretroviral therapyAllison Martin, Cecilia L Moore, Patrick W G Mallon, et al.
Targeted Oncology|July 15, 2020
Identifying Prostate Surface Antigen Patterns of Change in Patients with Metastatic Hormone Sensitive Prostate Cancer Treated with Abiraterone and PrednisoneIris Y Sheng, Jaleh Fallah, Ruby Gupta, et al.
Lung|March 6, 2023
The Efficacy and Safety of Gefapixant in a Phase 3b Trial of Patients with Recent-Onset Chronic CoughLorcan McGarvey, Mandel Sher, Yury Grigorievich Shvarts, et al.
Pageof 12